3David C, Kluth,Andrew J. Anti-glomerular basement membrane disease. J Am Soc Nephrol, 1999, (10) :2446.
4Lockwood CM, Rees AJ,Pearson TA et al. Immunosuppression and plasma exchage in the treatneat of Goodpasture's syndrome.Lancet, 1976,1:711.
5Pusey CD, Rees AJ, Evans DJ et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int, 1991,40: 757.
6Alan DS,Jeremy BL, Liz L et al. Goodpasture's disease.Lancet,2001,358:917.
7Frank M, Kai-Olaf N, Oliver G et al. Thearapeutic options for critically ill patients suffering frown progressive lupus nephritis or Goodpasture's syndrome.Kidney Int, 1998,53(Suppl 64) :S31.
8Bygren P, Christian F, Tore L et al. Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet, 1985,2(8467) : 1295.
9Esnault VL,Testa A, Jayne DR et al. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonepbritis. Nephron, 1993,65 : 180.
10Moreso F, Poveda R, Gil-Vernet S et al. Therapeutic immunoadsorption in Goodpasture disease. Med Clin (Barc), 1995,105(2) :59.
8Sakaida E, Nakaseko C, Hariam A, et al. Late-onset non-infectious pulmonary complications after allogeneic bone marrow transplantation are significantly associated with chronic graft-versushost disease and graft-versus-leukemia effect. Blood, 2003,101 : 4236-4242.
9Duncker C, Dohr D, Harsdorf S, et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single centre study of incidence, risk factors and outcome. Bone Marrow transplant,2000,25 : 1263-1268.
